Medium Potency Topical Corticosteroid Options

Classification and Clinical Applications

Medium potency topical corticosteroids are effective for treating various inflammatory skin conditions and can be used for longer courses than high potency steroids due to their more favorable adverse event profile, according to the American Academy of Dermatology 1
The American Academy of Dermatology recommends medium potency topical corticosteroids, such as Fluticasone propionate 0.05% (cream) and Mometasone furoate 0.1% (cream), for the treatment of inflammatory skin conditions 1, 3

The American Academy of Dermatology suggests applying medium potency topical corticosteroids once or twice daily to affected areas, with a maximum duration of 12 weeks for active disease 1, 4
For maintenance therapy, the American Academy of Dermatology recommends considering twice weekly application (e.g., weekends only) to prevent relapses in chronic conditions 1

Medium potency steroids have a lower risk of skin atrophy compared to high potency options, but still require monitoring, according to the American Academy of Dermatology 1, 4
The American Academy of Dermatology advises avoiding the use of medium potency topical corticosteroids on the face, intertriginous areas, and genitals, and monitoring for skin atrophy, telangiectasia, and tachyphylaxis with regular skin checks during long-term therapy 3, 4, 6

The American Academy of Dermatology recommends using lower potencies when possible in children and monitoring growth with long-term use 4